How is GazetAI different from Apple News or Google News?

Other apps show you everything. GazetAI shows you only what matters — and analyzes each story across 19 dimensions before you even open it.

Why can't I just read the news myself?

The world publishes 2+ million articles every day. Reading them all at 250 words per minute would take 130 years — without sleeping. The average person sees about 0.0005% of what's published. GazetAI's AI reads everything and surfaces only the stories that actually matter to you.

Do I need to read the full article?

No. The AI summary and analysis dashboard give you the full picture in under a minute. Open the original only if you want to.

What does the free trial include?

Full access to 3 categories for 7 days. No charge unless you continue.

Can I cancel anytime?

Yes. Cancel from the app or your billing portal. You keep access until the end of your billing period.

What languages are supported?

9 languages: English, Spanish, French, German, Portuguese, Arabic, Japanese, Chinese, Russian. Every analysis is fully translated.

Where do the news come from?

We aggregate from 50,000+ professional sources, then enrich every article with our AI pipeline.

← All Health news

Alamar launches commercial eMTBR-Tau blood immunoassay

1 min read

Alamar Biosciences on July 7, 2026 launched the first commercial eMTBR-Tau immunoassay, the company said in a Globe Newswire release. The assay is included in NULISAseq Neuro 220 multiplexed panel kits, is immediately deployable on the installed base of ARGO HT instruments, and is available as a single-plex through Alamar's Technology Access Program (TAP). eMTBR-Tau is a plasma biomarker that reflects tau tangle pathology and has shown strong associations with cognitive decline, clinical disease staging and therapeutic response monitoring in Alzheimer's disease, potentially enabling more precise patient staging and trial monitoring.

Alamar launched the first commercial eMTBR-Tau immunoassay.

The full analysis

19 dimensions on this story — world impact, market read, and what happens next.

Full ContextLocked
Affected SectorsLocked
Stock ImpactLocked
Economic IndicatorLocked
Investor RelevanceLocked
Professional RelevanceLocked
Watch PointsLocked
Probability of ChangeLocked
Debate PointsLocked
Prerequisite KnowledgeLocked
Follow-up QuestionsLocked
Pros & ConsLocked

Start your 7-day free trial